General Information of Drug (ID: DM57O90)

Drug Name
Zolgensma Drug Info
Synonyms Onasemnogene abeparvovec-xioi
Indication
Disease Entry ICD 11 Status REF
Spinal muscular atrophy 8B61 Approved [1]
Cross-matching ID
TTD Drug ID
DM57O90

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
LMI070 DM4OAIU Spinal muscular atrophy 8B61 Phase 3 [2]
RG7800 DMAGE91 Spinal muscular atrophy 8B61 Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Survival motor neuron protein (SMN1) TT8QL6X SMN_HUMAN Not Available [1]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy. Assay Drug Dev Technol. 2014 August 1; 12(6): 315-341.